Cultured human melanocytes express functional Toll-like receptors 2-4, 7 and 9

Journal of Dermatological Science

Volumn 56, Issue 2, 2009, Pages 113-120

  Yu, Ning ^a   Zhang, Shujie ^b   Zuo, Fuguo ^a   Kang, Kefei ^a   Guan, Ming ^a   Xiang, Leihong ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Inflammation; Innate immunity; Melanocyte; NF B; Toll like receptors

Indexed keywords

CYTOKINE; I KAPPA B; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR RELA;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; INNATE IMMUNITY; MELANOCYTE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL5; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; I-KAPPA B PROTEINS; IMMUNITY, INNATE; INFANT, NEWBORN; INTERLEUKIN-6; INTERLEUKIN-8; LIGANDS; MALE; MELANOCYTES; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR RELA;

EID: 70349838270     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.08.003     Document Type: Article

References (44)

1. Kupper T.S., and Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4 (2004) 211-222
2. Miller L.S., and Modlin R.L. Human keratinocyte Toll-like receptors promote distinct immune responses. J Invest Dermatol 127 (2007) 262-263
3. Mackintosh J.A. The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin. J Theor Biol 211 (2001) 101-113
4. Al Badri A.M., Foulis A.K., Todd P.M., Gariouch J.J., Gudgeon J.E., Stewart D.G., et al. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J Pathol 169 (1993) 203-206
5. Lu Y., Zhu W.Y., Tan C., Yu G.H., and Gu J.X. Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytes. Pigment Cell Res 15 (2002) 454-460
6. Yohn J.J., Critelli M., Lyons M.B., and Norris D.A. Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol 95 (1990) 233-237
7. Smit N., Le Poole I., van den Wijngaard R., Tigges A., Westerhof W., and Das P. Expression of different immunological markers by cultured human melanocytes. Arch Dermatol Res 285 (1993) 356-365
8. Swope V.B., Sauder D.N., McKenzie R.C., Sramkoski R.M., Krug K.A., Babcock G.F., et al. Synthesis of interleukin-1 alpha and beta by normal human melanocytes. J Invest Dermatol 102 (1994) 749-753
9. Krüger-Krasagakes S., Krasagakis K., Garbe C., and Diamantstein T. Production of cytokines by human melanoma cells and melanocytes. Recent Results Cancer Res 139 (1995) 155-168
10. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
11. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 1 (2001) 135-145
12. Barton G.M., and Medzhitov R. Toll-like receptor signaling pathways. Science 300 (2003) 1524-1525
13. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D., and Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 277 (2002) 15107-15112
14. Ohashi K., Burkart V., Flohé S., and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164 (2000) 558-561
15. Johnson G.B., Brunn G.J., Kodaira Y., and Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168 (2002) 5233-5239
16. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276 (2001) 10229-10233
17. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., and Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279 (2004) 17079-17084
18. West A.P., Koblansky A.A., and Ghosh S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22 (2006) 409-437
19. Kawai K., Shimura H., Minagawa M., Ito A., Tomiyama K., and Ito M. Expression of functional Toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci 30 (2002) 185-194
20. Song P.I., Park Y.M., Abraham T., Harten B., Zivony A., Neparidze N., et al. Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 119 (2002) 424-432
21. Mempel M., Voelcker V., Köllisch G., Plank C., Rad R., Gerhard M., et al. Toll-like receptor expression in human keratinocytes: nuclear factor kappa B controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121 (2003) 1389-1396
22. Lebre M.C., van der Aar A.M., van Baarsen L., van Capel T.M., Schuitemaker J.H., Kapsenberg M.L., et al. Human keratinocytes express functional Toll-like receptor 3-5, and 9. J Invest Dermatol 127 (2007) 331-341
23. Matsumoto M., Kikkawa S., Kohase M., Miyake K., and Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293 (2002) 1364-1369
24. Miller L.S. Toll-like receptors in skin. Adv Dermatol 24 (2008) 71-87
25. Anderson W. Immunities of empire: race, disease, and the new tropical medicine, 1900-1920. Bull Hist Med 70 (1996) 94-118
26. Blank F., Mann S.J., and Reale R.A. Distribution of dermatophytosis according to age, ethnic group and sex. Sabouraudia 12 (1974) 352-361
27. Gunathilake R., Schurer N.Y., Shoo B.A., Celli A., Hachem J.P., Crumrine D., et al. pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol 129 (2009) 1719-1729
28. Esen N., Tanga F.Y., DeLeo J.A., and Kielian T. Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J Neurochem 88 (2004) 746-758
29. Hajjar A.M., O'Mahony D.S., Ozinsky A., Underhill D.M., Aderem A., Klebanoff S.J., et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166 (2001) 15-19
30. Satta N., Kruithof E.K., Reber G., and de Moerloose P. Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides. Mol Immunol 46 (2008) 145-157
31. Quesniaux V.J., Nicolle D.M., Torres D., Kremer L., Guérardel Y., Nigou J., et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 172 (2004) 4425-4434
32. Baroni A., Orlando M., Donnarumma G., Farro P., Iovene M.R., Tufano M.A., et al. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res 297 (2006) 280-288
33. Gray J.S., Bae H.K., Li J.C., Lau A.S., and Pestka J.J. Double-stranded RNA-activated protein kinase mediates induction of interleukin-8 expression by deoxynivalenol, Shiga toxin 1, and ricin in monocytes. Toxicol Sci 105 (2008) 322-330
34. Kuyama M., Nakanishi G., Arata J., Iwatsuki K., and Fujimoto W. Expression of double-stranded RNA-activated protein kinase in keratinocytes and keratinocytic neoplasia. J Dermatol 30 (2003) 579-589
35. Grimes P.E., Sevall J.S., and Vojdani A. Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo. J Am Acad Dermatol 35 (1996) 21-26
36. Antony F.C., and Marsden R.A. Vitiligo in association with human immunodeficiency virus infection. J Eur Acad Dermatol Venereol 17 (2003) 456-458
37. Ahn J.H., Park T.J., Jin S.H., and Kang H.Y. Human melanocytes express functional Toll-like receptor 4. Exp Dermatol 17 (2008) 412-417
38. Ahn J.H., Jin S.H., and Kang H.Y. LPS induces melanogenesis through p38 MAPK activation in human melanocytes. Arch Dermatol Res 300 (2008) 325-329
39. Basu S., Binder R.J., Suto R., Anderson K.M., and Srivastava P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12 (2000) 1539-1546
40. Kroll T.M., Bommiasamy H., Boissy R.E., Hernandez C., Nickoloff B.J., Mestril R., et al. 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J Invest Dermatol 124 (2005) 798-806
41. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 12 (1994) 991-1045
42. Kang H.Y., Park T.J., and Jin S.H. Imiquimod, a Toll-like receptor 7 agonist, inhibits melanogenesis and proliferation of human melanocytes. J Invest Dermatol 129 (2009) 243-246
43. Kumagai Y., Takeuchi O., and Akira S. TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 60 (2008) 795-804
44. Dorn A., Ludwig R.J., Bock A., Thaci D., Hardt K., Bereiter-Hahn J., et al. Oligonucleotides suppress IL-8 in skin keratinocytes in vitro and offer anti-inflammatory properties in vivo. J Invest Dermatol 127 (2007) 846-854